Arcadia Investment Management Corp MI Has $2.32 Million Stock Holdings in Phreesia, Inc. (NYSE:PHR)

Arcadia Investment Management Corp MI cut its holdings in shares of Phreesia, Inc. (NYSE:PHR) by 5.1% during the 4th quarter, Holdings Channel reports. The institutional investor owned 92,155 shares of the company’s stock after selling 4,930 shares during the quarter. Arcadia Investment Management Corp MI’s holdings in Phreesia were worth $2,319,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of PHR. Handelsbanken Fonder AB increased its stake in shares of Phreesia by 23.5% in the 4th quarter. Handelsbanken Fonder AB now owns 12,600 shares of the company’s stock valued at $317,000 after acquiring an additional 2,400 shares in the last quarter. Peregrine Capital Management LLC increased its stake in shares of Phreesia by 0.8% in the 4th quarter. Peregrine Capital Management LLC now owns 319,327 shares of the company’s stock valued at $8,034,000 after acquiring an additional 2,531 shares in the last quarter. Venturi Wealth Management LLC bought a new stake in shares of Phreesia in the 4th quarter valued at $76,000. Rhumbline Advisers increased its stake in shares of Phreesia by 7.4% in the 4th quarter. Rhumbline Advisers now owns 83,631 shares of the company’s stock valued at $2,104,000 after acquiring an additional 5,756 shares in the last quarter. Finally, R Squared Ltd bought a new stake in shares of Phreesia in the 4th quarter valued at $30,000. Institutional investors and hedge funds own 92.10% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have commented on the stock. KeyCorp boosted their price target on shares of Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a research note on Wednesday, January 8th. Needham & Company LLC restated a “buy” rating and set a $29.00 price target on shares of Phreesia in a research note on Friday, January 10th. Truist Financial boosted their price target on shares of Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. JMP Securities restated a “market outperform” rating and set a $30.00 price target on shares of Phreesia in a research note on Tuesday, December 10th. Finally, Royal Bank of Canada upgraded shares of Phreesia from a “sector perform” rating to an “outperform” rating and boosted their price target for the company from $24.00 to $32.00 in a research note on Wednesday, January 8th. Thirteen equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $31.15.

Insider Buying and Selling

In related news, CFO Balaji Gandhi sold 28,759 shares of the business’s stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $30.00, for a total value of $862,770.00. Following the transaction, the chief financial officer now directly owns 116,174 shares of the company’s stock, valued at approximately $3,485,220. The trade was a 19.84 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Michael Weintraub sold 15,152 shares of the business’s stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $21.01, for a total transaction of $318,343.52. Following the completion of the transaction, the director now directly owns 242,827 shares in the company, valued at $5,101,795.27. This trade represents a 5.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 236,339 shares of company stock valued at $6,292,359. 5.80% of the stock is owned by insiders.

Phreesia Trading Down 4.0 %

NYSE PHR opened at $28.49 on Friday. Phreesia, Inc. has a 1 year low of $17.07 and a 1 year high of $30.53. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. The company has a fifty day moving average price of $27.22 and a 200-day moving average price of $23.80.

Phreesia (NYSE:PHR) last issued its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.04. The company had revenue of $106.80 million for the quarter, compared to the consensus estimate of $106.33 million. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The firm’s quarterly revenue was up 16.6% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.58) EPS. As a group, sell-side analysts anticipate that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.